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Cervical cancer in South Africa (SA), as in most 
developing countries, remains an unchecked epi­
demic.[1­3] Although reasons for the high prevalence 
and late presentation are complex, poor uptake of 
screening plays a major role. Together with health 
systems factors, educational level and knowledge determine health­
seeking behaviour and therefore screening coverage. Many authors 
have investigated knowledge about cervical cancer among SA women, 
and have generally reported this to be lacking.[4­7]
It is expected that improved knowledge of cervical cancer will 
translate into an improvement in screening uptake. If knowledge can 
be improved by verbal or written communication, parents of human 
papillomavirus (HPV) vaccine recipients would be an appropriate 
target for such an educational drive. These mothers are not realistic 
targets for primary prevention, but should be in the appropriate 
age group for screening. In addition, information about the two 
modalities of prevention seems to combine well.
Linking various health interventions to school­based HPV 
vaccination is a popular idea because preadolescents generally do not 
present for health information or care.[8­10] Potential disadvantages 
include a diluted message, increased cost and the possibility that 
connecting this vaccine to sexual health may decrease uptake. It is 
therefore essential that any planned health intervention be evalua­
ted and motivated thoroughly before implementation.
The main aim of this project was to investigate whether an edu­
cational drive to improve knowledge and screening of mothers can 
be successful when linked to school­based HPV vaccination. In order 
to answer this question, knowledge and screening behaviour were 
tested before and after an educational intervention, followed by an 
invitation to participate in screening.
Methods
The Vaccine and Cervical Cancer Screen (VACCS) project aimed to 
vaccinate 2 000 primary schoolgirls in Gauteng Province (GP) and the 
Western Cape (WC) during 2011 and 2012, after approval from the 
national and provincial departments of health and basic education. 
The study was also approved by the institutional research ethics review 
committees of the universities of Pretoria (219/2009) and Stellenbosch 
(N11/01/008). Schools were selected on the basis of geographical 
distribution and consent from headmasters and school governing 
bodies. Printed information, consent and invitation material was 
distributed to all girls in grades 4 ­ 7. These pamphlets invited parents 
to consent to vaccination of their daughters and to attend information 
events at schools where they would receive more detailed information.
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Background. Poor knowledge about cervical cancer plays a role in limiting screening uptake. HPV vaccination provides an untested 
platform to distribute information that could possibly improve knowledge and screening coverage.
Objective. To measure changes in knowledge and screening uptake when information and screening opportunities were provided to 
mothers of adolescent HPV vaccine recipients.
Methods. During an HPV vaccine implementation project in the Western Cape (WC) and Gauteng Province (GP), South Africa, 
information about cervical cancer was provided to parents during a lecture, written information was distributed, and mothers were then 
invited to either screen at their clinic (WC) or use a self­screening kit (GP). A structured questionnaire was used to test cervical cancer 
knowledge and screening practices, comparing these before and after the project and between the two screening groups.
Results. Complete data for both questionnaires were available for 777 of 906 recruited women. Initial knowledge was poor, but on retesting 
6 months later, knowledge about symptoms (p<0.005), screening (p<0.005) and vaccination (p<0.05) improved significantly after the 
information session and school­based HPV vaccination. In the second questionnaire, women reported significantly more screening and 
the last reported screening test was more recent. This improvement was more favourable in GP than in the WC (41% v. 26% reporting 
screening in the past 12 months).
Conclusion. These results demonstrate how adolescent HPV vaccine programmes can help to control cervical cancer among mothers by 
offering information and screening. It is important not to lose this opportunity to educate mothers and their daughters and offer effective 
methods to prevent cervical cancer in both generations.
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After receiving information about the project, parents and female 
guardians were invited to participate in a questionnaire study and had 
to provide written consent. The questionnaire (Q1) contained both 
open­ended and closed questions on demographics and aspects of 
cervical cancer and its prevention, and was administered by medical 
students who asked the questions and recorded answers. The educational 
intervention followed, consisting of a 15­minute PowerPoint presentation 
by a medical doctor and information leaflets covering most of the 
information assessed in the questionnaire. Parents and daughters were 
invited to sign consent and assent for the girl child to be vaccinated, and 
all mothers were invited to partake in cervical cancer screening.
Two different types of screening were employed in the two study 
sites to evaluate and compare impact on screening behaviour. In the 
WC, where cervical screening services are better developed, mothers 
were encouraged to visit their nearest clinic and undergo conventional 
cytology­based screening. In GP, female parents and guardians were 
offered a tampon collection kit for HPV determination with written 
information on how to self­collect the sample. These specimens were 
collected from the school during the following month and tested for 
high­risk HPV, and women who screened positive received results and 
an invitation to further investigation and treatment if necessary. [11] All 
women received results via cell phone messaging (texting).
During the following months, vaccination took place at the 
school and telephonic interviews were conducted with the mothers 
after 6 months, repeating the same questions (Q2). Data from the 
two questionnaires were analysed to determine levels of knowledge 
and self­reported screening behaviour before and after the study. 
Differences between the answers were determined for each participant 
and analysed. Outcomes of the vaccination programme and the main 
results of the self­screening study have been reported elsewhere.[12]
Data management
Questionnaire data consisted of basic demographic data, information 
about access to and use of healthcare facilities, knowledge of cervical 
cancer and previous cervical cancer screening. Questions were 
asked to test basic knowledge about cervical cancer and protection 
against the disease, followed by questions on previous cervical 
cancer screening tests and their results. Using these data, knowledge 
scores were calculated by awarding points for correct answers to a 
maximum score of 5 marks each for knowledge about cervical cancer 
symptoms, screening options and vaccination (the scoring system is 
shown in Appendix 1, available in the online version of this article). 
For each of these three, a critical minimum score was determined 
based on information supplied at the lecture. It was then calculated 
in terms of how many women’s knowledge improved to this critical 
minimum between the first and second questionnaires.
Because two different methods were employed to impact on 
screening behaviour at the two study sites, data on changes in 
screening uptake were analysed separately for these two groups. 
For screening behaviour, a score was calculated (behaviour score) 
according to the time of the last reported screening test. After 
completing the questionnaire at the start and end of the study, all 
participants who improved their ‘time of last screening test’ to <1 year 
ago were considered study screen participants.
Results
Demographic data
We invited all attending parents to participate in the study, of whom 
only two were excluded (male parents were ineligible). Questionnaire 
data were available for 906 women, and 777 also completed the 
second questionnaire. Loss to follow­up was due to inability to make 
telephonic contact or refusal to answer Q2. Demographics of this 
group were not different to the total group. The median age of the 
participants was 38.0 years and the level of education varied between 
very little formal schooling (up to grade 7 in 10.1% of women) and 
tertiary education (23.3% of women). Half of all participants received 
a salary and another 6.8% were self­employed. Differences between 
the provinces were significant, with parents at the GP schools being 
slightly younger and better educated.[13]
Knowledge about cervical cancer and its symptoms 
before and after health education
Before the educational intervention, knowledge about cervical cancer 
and its symptoms was similarly poor among participants in both sites, 
with 31.7% of the total group (n=906) saying that they knew nothing 
about cervical cancer or did not know what it was. Among those 
who answered questions about the symptoms of cervical cancer, pain 
was mentioned most commonly as an important symptom (30.0%), 
followed by discharge (20.9%). Significantly more women in the WC 
cohort than in GP knew that unusual bleeding was a symptom (24.0% 
v. 18.3%; p=0.04). In the second interview, only 11.9% of respondents 
said that they knew nothing about cervical cancer. Knowledge 
about the important symptoms of the disease improved, and 46.8% 
respondents mentioned pain, 42.1% unusual bleeding and 32.0% 
discharge. These answers are shown in Appendices 2 and 3 (available 
in the online version of this article).
Knowledge about cervical cancer prevention  
before and after health education
With regard to cervical cancer prevention, 53.1% of respondents 
initially said that they knew how a woman can protect herself against 
the disease; 86.1% of these women (24.6% of the total) mentioned 
a Pap smear as protective. Other answers included some form of 
medical care, protective sexual practices such as condoms, vaccines, 
or not having sex (only 2.4%).
After the health education intervention, 83.3% of respondents 
thought that they knew how to protect against cervical cancer. In 
the total group, 66.5% now mentioned ‘Pap smear’ as protective. The 
biggest change was seen in knowledge that the vaccine exists, which 
increased from 4.2% to 26.3%. These data were also elicited by an 
open­ended question, and some answers are shown in Appendix 4 
(available in the online version of this article).
When asked whether they had ever heard of a vaccine against 
cervical cancer, 17.2% answered ‘yes’ before the project, and 84.1% 
at the end of the project. Only 15.9% of participants attempted to 
answer the question on preferred recipients of HPV vaccines, mostly 
correctly. However, attitude towards and trust in vaccines were very 
positive, with 90.6% of respondents saying that the vaccine will be 
good to have, and 89.8% saying that they would advise primary 
schoolgirls to have it. Responses to these last two questions at the end 
of the study were even better (97.4% and 98.1%).
Knowledge scores and changes after intervention
Using the method described above, knowledge scores were calculated 
both before and after the information event and compared per 
participant for those women who completed both questionnaires. 
Data for the complete group are set out in Table 1, showing a trend 
of improvement in knowledge scores (graphically illustrated in 
Diagrams 1 ­ 3, available in the online version of this article).
According to the critical or essential level of knowledge, 
participants were divided into three groups: those whose knowledge 
scores improved to adequate levels, those who remained at the same 
level of adequacy, and those who demonstrated poorer knowledge at 
the second interview.
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Initially, 30.8% of participants (239/777) attained a knowledge score of 
0/5 for cervical cancer and its symptoms, considered to be inadequate, 
while only 9.1% remained at a knowledge score of 0 after attending 
the health education event. In 21.6% of women knowledge scores 
improved to a level of adequacy. The improvement was statistically 
significant (p<0.005) and the data are shown in Table 2 (A).
Similarly, for cervical cancer screening any knowledge score above 
0/5 was considered adequate for the purposes of this analysis. After 
education, 62.9% had confirmed adequate knowledge, v. 30.6% 
before. Improvement per person was also statistically significant 
(p<0.005) (Table 2, B).
Scoring for vaccine knowledge included two questions that actually 
tested attitude towards vaccines, requiring a ‘yes’ or ‘no’ answer. In 
view of the positive attitudes towards vaccines in general, vaccine 
knowledge scores were generally good. A minimum score of 3/5 was 
considered adequate and was attained by 17.6% at the start of the 
study and 80.8% at the end of this study (p=0.045) (Table 2, C).
Screening behaviour scores and changes  
after the intervention
Women were asked whether they ever had a cervical cancer test and 
how long ago the last test had been. Answers were used to calculate a 
screening behaviour score, and scores of 0/5 were awarded for ‘never’ 
or ‘unsure if ever’, 1/5 for ‘more than 10 years ago’ and so on, with 
a score of 5/5 for a test ‘less than a year ago’. Changes in screening 
behaviour for the whole group are shown for ‘ever’ v. ‘never’ and for 
Table 1. Knowledge scores before and after health education for all women who completed Q1 and Q2 (N=777)














0 239 115 539 288 43 34
1 215 199 150 254 45 16
2 135 152 67 135 552 99
3 109 163 18 61 32 76
4 68 131 2 39 17 15
5 11 17 1 0 88 537
 = considered adequate knowledge score; = considered inadequate knowledge score.
Table 2. Changes in knowledge scores
Questionnaire 1 Questionnaire 2 Questionnaire 1 totals









Score 1 ­ 5
44 494 538
Questionnaire 2 totals 115 662 777









Score 1 ­ 5
53 185 238
Questionnaire 2 totals 288 489 777
C. Changes in knowledge scores about cervical cancer protection by vaccination (p<0.05)
Inadequate knowledge
Score 0 - 2
Adequate knowledge
Score 3 - 5
Inadequate knowledge
Score 0 ­ 2
133 507 640
Adequate knowledge
Score 3 ­ 5
16 121 137
Questionnaire 2 totals 149 628 777
 = improvement in score; = score unchanged; = decrease in score.
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‘less than 1 year ago’ v. ‘more than a year ago’ 
in Table 3. Using both cut­offs, a significant 
improvement was demonstrated over the 
study period (p<0.005).
Screening behaviour in the  
two sites
The initial self­reported screening behaviour 
for the two provincial sites showed no 
significant differences. Changes in screening 
behaviour reflected significantly more recent 
screening after the health education at both 
sites. In GP, where self­screening was also 
offered, changes in screening behaviour were 
more favourable (Fig. 1).
The improvement in screening behaviour 
as reported by women themselves under­
estimated the impact of this health inter­
vention in the GP site, when com pared with 
the self­screening data. It was confirmed 
that 253 of the 558 women (45.3%) who 
completed Q1 handed in a self­collected 
screening test, while only 51 women moved 
to the ‘less than 1 year ago’ category in Q2.
Among participants in the WC, the num­
ber of women reporting ‘never’ screening 
decreased and those who reported ‘more 
than 1 year ago’ increased, suggesting that 
the health information motivated women 
to improve screening behaviour. However, 
a search through the data system of the 
National Health Laboratory Service could 
not confirm recent screening at this 
laboratory (which services all public health 
care facilities) in more than a very limited 
number of participants.
Discussion
This study showed that simple health edu­
cation during a vaccine implementation 
project can have a measurable effect on 
the knowledge of mothers of primary 
schoolchildren and that significant 
improvements in knowledge about 
symptoms, screening and vaccination could 
be demonstrated. Importantly, we also 
demonstrated that increased knowledge 
scores can be linked to improved screening 
behaviour when opportunities for screening 
were easy to access.[11] Lack of knowledge 
about disease detection and prevention 
has often been linked to high prevalence 
and late diagnosis of cervical cancer, but 
evidence about interventions to address this 
problem effectively is limited.[4] Consistent 
with previous reports, the present study 
confirmed that many SA women at risk for 
cervical cancer lack even the most basic 
knowledge about the disease and how they 
can protect themselves.[5,6]
These results support HPV vaccination 
campaigns as a potential platform to supply 
health information about cervical cancer 
that can influence screening decisions. 
Mothers and other female guardians of 
primary schoolchildren are at the ideal age 
for cervical screening and are socially and 
economically critically important. During 
this study the educational intervention 
consisted of a combination of an oral 
presentation and written material, which will 
probably not be possible on a nationwide 
scale. Although alternative educational 
initiatives should preferably be tested before 
wide implementation, a minimum of written 
Table 3. Self-reported screening behaviour
Questionnaire 1 Questionnaire 2 Questionnaire 1 totals









Score 1 ­ 5
33 358 391
Questionnaire 2 totals 227 502 729
B. Screening before v. during the past year (p<0.005)
Screened >1 year ago
Score 0 - 4
Screened ≤1 year ago
Score 5
Screened >1 year ago
Score 0 ­ 4
421 134 555
Screened ≤1 year ago
Score 5
44 130 174
Questionnaire 2 totals 465 264 729


























Fig. 1. Self-reported screening behaviour before and after health intervention for the two sites. 
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educational material should be offered addressing the risk of non­
vaccinated women and offering alternative cancer prevention via 
screening.[8]
Answers to questions that tested attitude toward vaccination in 
general were overwhelmingly positive, with parents showing health­
seeking behaviour where their children were involved. The positive 
attitude towards vaccines may also reflect previous good experiences 
with the childhood vaccine programme. We trust that these positive 
results will contribute to widespread acceptance and successful 
introduction of the new and essential HPV vaccines in SA and similar 
developing countries.
Women offered on­site self­screening had a larger improvement 
in self­reported screening behaviour than those invited to use 
existing facilities.[11] The uptake of the test was calculated and the 
results support this finding. Observed uptake of self­screening was 
higher than what was reported by the respondents, cautioning that 
women did not understand that this test was indeed a new type of 
cancer screening test. Improvements in self­reported screening data 
among participants who were invited to screen at existing clinics were 
not supported by other data sources available to us and should be 
interpreted with caution.
Study limitations
Limitations of our study include the inherent limitations of 
administered questionnaires, difficulties in assessing knowledge and 
attitudes accurately using a questionnaire, and the potential inaccuracy 
of self­reported data on the use of health services. Inconsistent data 
on screening behaviour between the two questionnaires and between 
women’s reports and other data sources demonstrate this inaccuracy. 
Women may not recall the time since their last screening test 
accurately, and the results of these questions may also be influenced 
by social desirability bias.
Conclusion
The results of this questionnaire study demonstrate that knowledge 
about cervical cancer among SA women at risk for the disease is 
lacking, but can be improved significantly by simple educational 
interventions. School­based HPV vaccination programmes provide 
an opportunity for successful education that can include information 
about vaccination and screening.
Additionally, this project showed that HPV vaccine programmes 
can be used to improve cervical cancer screening coverage. Self­
collected molecular tests that were provided at the information 
events achieved higher uptake than a reminder to use the existing 
clinic­based service, and all women received results using school­
based logistics.
It is hoped that the overwhelmingly positive attitude towards 
vaccination found during this study predicts a high uptake of pre­
adolescent HPV vaccine outside the research setting.
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Diagram 1. Knowledge of cervical cancer symptoms.
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Appendix 1. Calculation of knowledge scores from responses in questionnaires 1 and 2




301 & 601. Can you explain what 
you understand about cervical 
cancer – that is cancer of the 
mouth of the womb?
Do not know
Any correct or nearly correct answer
0
1
303 & 603. What changes in your 
body would make you think that 










304 & 604. How can a 
woman protect herself against 
developing cervical cancer?
Regular pap smear










501 & 801. Have you ever heard 
of a vaccine or injection to 
prevent cervical cancer?
Yes 1 
502 & 802. IF YES: Who is the 
vaccine or injection for?
Women/girls only
Men and women/girls
Women/girls under a certain age
Women/girls who have not had 
sexual intercourse yet
2 points each
503 & 803. Do you think a 
vaccine to prevent cervical 
cancer would be good to have?
Yes 1
505 & 805. Would you advise 
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Don’t know/nothing 308 (41.0) 112 (15.7)
Cancer of the mouth of the womb or cervix 69 (9.2) 175 (24.5)
Cancer, illness, growth, sores or bleeding of the 
womb
192 (25.6) 278 (38.9)
Must have Pap smears 33 (4.4) 10 (1.4)
Cancer of private parts/affects only women 27 (3.6) 53 (7.4)
STD/can get from unsafe sex 31 (4.1) 34 (4.8)
HPV/virus 5 (0.7) 12 (1.7)
Self, friend, family member has it 6 (0.8) 2 (0.3)
Type of cancer 12 (1.6) 3 (0.4)
Abnormal cells, growth, lump, mass, cyst 9 (1.2) 1 (0.1)
Dangerous, fatal, incurable disease 19 (2.5) 6 (0.8)
Affects vagina 13 (1.7) 15 (2.1)
Appendix 3. Answers to open-ended question: ‘What changes in the body would make 








Pain 272 (30.0) 359 (46.2)
Discharge 189 (20.9) 249 (32.0)
Odour 92 (10.1) 137 (17.6)
Ulcers/sores 64 (7.1) 140 (18.0)
Unusual bleeding 185 (20.4) 327 (42.1)
There are no signs 11 (1.2) 8 (1.0)
Don’t know 71 (7.8) 90 (11.6)








Pap smear 223 (24.6) 419 (53.9)
Regular examination of womb 74 (8.2) 126 (16.2)
Seeing a special doctor 38 (4.2) 124 (16.0)
Regular visit to general practitioner 30 (3.3) 43 (5.5)
Not having sex 22 (2.4) 18 (2.3)
Using condoms 61 (6.7) 113 (14.5)
Vaccine/injection 38 (4.2) 205 (26.4)
Other screening tests 21 (2.3) 28 (3.6)
